| Community-led, integrated, reproducible multi-omics with anvi’o AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... Nature microbiology 6 (1), 3-6, 2021 | 423 | 2021 |
| Functional and genetic markers of niche partitioning among enigmatic members of the human oral microbiome A Shaiber, AD Willis, TO Delmont, S Roux, LX Chen, AC Schmid, ... Genome biology 21, 1-35, 2020 | 145 | 2020 |
| Community-led, integrated, reproducible multi-omics with anvi’o. Nat Microbiol 6: 3–6 AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... | 72 | 2021 |
| Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10–/–Mice J Miyoshi, S Miyoshi, TO Delmont, C Cham, STM Lee, A Sakatani, K Yang, ... Gastroenterology 161 (3), 940-952. e15, 2021 | 23 | 2021 |
| The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review A Sarkar, S Omar, A Alshareef, K Fanous, S Sarker, H Alroobi, F Zamir, ... Human Vaccines & Immunotherapeutics 19 (1), 2212568, 2023 | 16 | 2023 |
| Statistically learning the functional landscape of microbial communities A Skwara, K Gowda, M Yousef, J Diaz-Colunga, AS Raman, A Sanchez, ... Nature Ecology & Evolution 7 (11), 1823-1833, 2023 | 11 | 2023 |
| Community-led, integrated, reproducible multi-omics with anvi’o. Nat Microbiol. 2021; 6: 3–6 AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... | 10 | |
| Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, P Edelkamp, ... NPJ Precision Oncology 8 (1), 27, 2024 | 3 | 2024 |
| Transient suppression of bacterial populations associated with gut health is critical in success of exclusive enteral nutrition for children with crohn’s disease J Runde, I Veseli, EC Fogarty, AR Watson, Q Clayssen, M Yosef, ... Journal of Crohn's and Colitis 17 (7), 1103-1113, 2023 | 2 | 2023 |
| Learning the functional landscape of microbial communities A Skwara, K Gowda, M Yousef, J Diaz-Colunga, AS Raman, A Sanchez, ... bioRxiv, 2023.03. 24.534159, 2023 | 2 | 2023 |
| Impact of KRAS Mutations and Co-mutations on Clinical Outcome in Pancreatic Ductal Adenocarcinoma D Zhao, A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, ... | 1 | 2023 |
| Early-life microbial intervention reduces colitis risk promoted by antibiotic-induced gut dysbiosis J Miyoshi, S Miyoshi, TO Delmont, C Cham, STM Lee, A Sakatani, K Yang, ... bioRxiv, 2020.03. 11.987412, 2020 | 1 | 2020 |
| Cell-type-specific gene programs suggest immune and stromal drivers of relapse in colorectal cancer NJ Hornstein, M Wang, A Yousef, S Chowdhury, F Zeineddine, ... Cancer Research 84 (6_Supplement), 881-881, 2024 | | 2024 |
| KRAS Q61 mutations in patients with gastrointestinal malignancies and association with real-world clinical outcomes M Yousef, A Yousef, S Chowdhury, MM Fanaeian, M Knafl, PM Roy, ... Cancer Research 84 (6_Supplement), 2547-2547, 2024 | | 2024 |
| The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review M Yousef, M Rob, S Varghese, S Rao, F Zamir, P Paul, A Chaari Life Sciences, 122535, 2024 | | 2024 |
| Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ... JAMA Network Open 7 (2), e240260-e240260, 2024 | | 2024 |
| Risk of relapse after surgical resection of localized appendiceal adenocarcinoma. MM Fanaeian, MMG Yousef, AMG Yousef, WC Foo, M Taggart, KA Beaty, ... Journal of Clinical Oncology 42 (3_suppl), 58-58, 2024 | | 2024 |
| Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME). BB Gunes, NJ Hornstein, M Wang, S Chowdhury, MMG Yousef, ... Journal of Clinical Oncology 42 (3_suppl), 760-760, 2024 | | 2024 |
| Frequency and oncologic outcomes of KRAS mutations in circulating tumor DNA of patients with pancreatic ductal adenocarcinoma. MMG Yousef, MW Hurd, AMG Yousef, RA Snyder, M Knafl, MM Fanaeian, ... Journal of Clinical Oncology 42 (3_suppl), 636-636, 2024 | | 2024 |
| Prognosis and clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. MMG Yousef, AMG Yousef, MW Hurd, EB Ludmir, EJ Koay, RA Snyder, ... Journal of Clinical Oncology 42 (3_suppl), 635-635, 2024 | | 2024 |
